Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 08:02 am Sale |
2022-12-31 | 13G | Acropolis Infrastructure Acquisition Corp. ACRO |
Citadel Advisors LLC | 2,241,549 6.500% |
-405,087 (-15.31%) |
Filing History |
| 2023-02-14 08:02 am Sale |
2022-12-31 | 13G | MSD Acquisition Corp. MSDA |
Citadel Advisors LLC | 3,428,296 6.000% |
-60,921 (-1.75%) |
Filing History |
| 2023-02-14 08:02 am Purchase |
2022-12-31 | 13G | Motive Capital Corp II MTVC |
Citadel Advisors LLC | 2,500,443 7.300% |
262 (+0.01%) |
Filing History |
| 2023-02-14 08:02 am Purchase |
2022-12-31 | 13G | Oncorus, Inc. ONCR |
Citadel Advisors LLC | 2,017,854 7.800% |
116,545 (+6.13%) |
Filing History |
| 2023-02-14 08:02 am Purchase |
2022-12-31 | 13G | Panacea Acquisition Corp. II PANA |
Citadel Advisors LLC | 1,501,251 8.400% |
273,545 (+22.28%) |
Filing History |
| 2023-02-14 08:02 am Purchase |
2022-12-31 | 13G | Jackson Acquisition Company RJAC |
Citadel Advisors LLC | 1,256,919 5.700% |
1,256,919 (New Position) |
Filing History |
| 2023-02-14 08:02 am Sale |
2022-12-31 | 13G | Talaris Therapeutics, Inc. TALS |
Citadel Advisors LLC | 352,217 8.400% |
-28,947 (-7.59%) |
Filing History |
| 2023-02-14 08:02 am Sale |
2022-12-31 | 13G | Vera Therapeutics, Inc. VERA |
Citadel Advisors LLC | 1,991,553 7.200% |
-50,867 (-2.49%) |
Filing History |
| 2023-02-14 08:02 am Purchase |
2022-12-31 | 13G | Vigil Neuroscience, Inc. VIGL |
Citadel Advisors LLC | 2,163,916 6.100% |
55,196 (+2.62%) |
Filing History |
| 2023-02-14 08:02 am Sale |
2022-12-31 | 13G | Ventyx Biosciences, Inc. VTYX |
Citadel Advisors LLC | 3,788,795 6.700% |
-102,278 (-2.63%) |
Filing History |
| 2023-02-14 08:02 am Purchase |
2022-12-31 | 13G | Aura Biosciences, Inc. AURA |
Citadel Advisors LLC | 2,737,053 7.400% |
421,951 (+18.23%) |
Filing History |
| 2023-02-14 08:02 am Purchase |
2022-12-31 | 13G | Artemis Strategic Investment Corporation ARTE |
Citadel Advisors LLC | 1,621,525 8.100% |
442,720 (+37.56%) |
Filing History |
| 2023-02-14 08:02 am Sale |
2022-12-31 | 13G | Aerovate Therapeutics, Inc. AVTE |
Citadel Advisors LLC | 44,628 6.400% |
-1,014 (-2.22%) |
Filing History |
| 2023-02-14 08:02 am Sale |
2022-12-31 | 13G | Acrivon Therapeutics, Inc. Common Stock ACRV |
Citadel Advisors LLC | 1,634,149 7.800% |
-488 (-0.03%) |
Filing History |
| 2023-02-14 08:02 am Sale |
2022-12-31 | 13G | ARYA Sciences Acquisition Corp V ARYE |
Citadel Advisors LLC | 1,062,378 6.900% |
-334 (-0.03%) |
Filing History |
| 2023-02-14 08:02 am Sale |
2022-12-31 | 13G | Bolt Biotherapeutics, Inc. BOLT |
Citadel Advisors LLC | 2,752,195 7.300% |
-60,254 (-2.14%) |
Filing History |
| 2023-02-14 08:02 am Sale |
2022-12-31 | 13G | Catcha Investment Corp CHAA |
Citadel Advisors LLC | 2,204,889 7.400% |
-337,950 (-13.29%) |
Filing History |
| 2023-02-14 08:02 am Purchase |
2022-12-31 | 13G | Decibel Therapeutics, Inc. DBTX |
Citadel Advisors LLC | 1,863,411 7.500% |
35,484 (+1.94%) |
Filing History |
| 2023-02-14 08:02 am Sale |
2022-12-31 | 13G | Elliott Opportunity II Corp. EOCW |
Citadel Advisors LLC | 3,134,685 5.100% |
-666,237 (-17.53%) |
Filing History |
| 2023-02-14 08:02 am Sale |
2022-12-31 | 13G | Conyers Park III Acquisition Corp. CPAA |
Citadel Advisors LLC | 1,877,136 5.300% |
-748,695 (-28.51%) |
Filing History |